Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas-Reference-Cited by-同舟云学术

Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas

Published:2018-05-07 Issue:7 Volume:77 Page:542-548
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:

Author:

Richardson Timothy E¹,Sathe Adwait Amod²,Kanchwala Mohammed²,Jia Gaoxiang³,Habib Amyn A⁴⁵,Xiao Guanghua³⁶,Snuderl Matija⁷,Xing Chao²³⁶,Hatanpaa Kimmo J¹

Affiliation:

1. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas

2. Eugene McDermott Center for Human Growth & Development, University of Texas Southwestern Medical Center, Dallas, Texas

3. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas

4. Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas

5. North Texas Veterans Affairs Medical Center, Dallas, Texas

6. Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas

7. Department of Pathology, New York University Langone Medical Center, New York City, New York

Funder

Friedberg Charitable Foundation

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://academic.oup.com/jnen/article-pdf/77/7/542/25056157/nly026.pdf

Reference57 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: A summary;Louis;Acta Neuropathol,2016

2. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005–2009;Dolecek;Neuro Oncol,2012

3. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010;Ostrom;Neuro Oncol,2013

4. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas;Sanson;J Clin Oncol,2009

5. Mutant metabolic enzymes are at the origin of gliomas;Yan;Cancer Res,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma;Acta Neuropathologica;2024-07-16

2. Refinement of prognostication for IDH‐mutant astrocytomas using DNA methylation‐based classification;Brain Pathology;2024-01-02

3. MYBL2: a novel aggressive biomarker in IDH-mutant Astrocytoma;2024-01-02

4. Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor types;Neuro-Oncology Advances;2024-01-01

5. CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma;Journal of Neuropathology & Experimental Neurology;2023-09-20